Upexi, Inc. (NASDAQ:UPXI) Short Interest Update

Upexi, Inc. (NASDAQ:UPXIGet Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 36,800 shares, an increase of 323.0% from the January 15th total of 8,700 shares. Approximately 4.9% of the company’s shares are sold short. Based on an average daily trading volume, of 157,000 shares, the short-interest ratio is currently 0.2 days.

Upexi Stock Performance

Shares of UPXI stock traded up $0.15 on Thursday, reaching $3.84. 11,502 shares of the stock were exchanged, compared to its average volume of 181,911. The company has a current ratio of 0.69, a quick ratio of 0.53 and a debt-to-equity ratio of 0.39. The firm has a 50 day moving average of $4.06 and a two-hundred day moving average of $4.37. Upexi has a 1-year low of $2.17 and a 1-year high of $28.00.

Upexi (NASDAQ:UPXIGet Free Report) last released its quarterly earnings data on Thursday, December 19th. The company reported ($1.55) EPS for the quarter.

Institutional Trading of Upexi

An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can purchased a new stake in Upexi, Inc. (NASDAQ:UPXIFree Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned approximately 0.81% of Upexi at the end of the most recent quarter. Institutional investors and hedge funds own 5.68% of the company’s stock.

Upexi Company Profile

(Get Free Report)

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

See Also

Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.